Submitted by Anonymous (not verified) on 6 November 2025 - 14:00
Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 38, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 38, Status: Authorised